1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
| Title | Type | Last modified |
|---|---|---|
| Increased risk of rhabdomyolysis with combined use of sodium fusidate and HMG-CoA reductase inhibitors | Story | 2013-06-18 02:28 |
| Actonel® available for once-a-month treatment of postmenopausal osteoporosis | Story | 2013-06-18 02:28 |
| Calcium Gluconate Gel Availability | Story | 2013-06-18 02:28 |
| Natalizumab | Newsletter issue | 2015-05-27 14:03 |
| Dementia Therapy, Memantine | Newsletter issue | 2015-05-27 13:56 |
| Rivastigmine | Newsletter issue | 2015-05-27 14:08 |
| Rasagiline | Newsletter issue | 2015-05-27 14:08 |
| Varenicline | Newsletter issue | 2015-05-27 14:16 |
| Rosuvastatin | Newsletter issue | 2015-05-27 14:09 |
| Pioglitazone | Newsletter issue | 2015-05-27 14:05 |